ResearcherChina Pharmaceutical UniversityActive in the last 2 years
Rong Hu
Matched on ORCID iD 0000-0003-2998-064X; OpenAlex author ID A5088499165. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Context-Dependent Spatial and Functional Roles of CD44 Across Pancreatic Ductal Adenocarcinoma States. Last author DOI 10.3390/cancers18203410↗
- HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling. Last author DOI 10.1016/j.redox.2019.101390↗
- Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway. Last author DOI 10.1016/j.redox.2019.101131↗
- ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1. Last author DOI 10.2139/ssrn.3439545↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yang Zhou · 3 shared papers, 2019–2020 · strength 0.31
- Paper HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling. DOI 10.1016/j.redox.2019.101390↗
- Paper ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1. DOI 10.2139/ssrn.3439545↗
- Paper Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway. DOI 10.1016/j.redox.2019.101131↗
- Yunjiang Zhou · 3 shared papers, 2019–2020 · strength 0.31
- Paper HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling. DOI 10.1016/j.redox.2019.101390↗
- Paper ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1. DOI 10.2139/ssrn.3439545↗
- Paper Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway. DOI 10.1016/j.redox.2019.101131↗
- Bin Fu · 1 shared paper, 2026 · strength 0.30
- Rui Wang · 2 shared papers, 2019–2020 · strength 0.21
- Paper HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling. DOI 10.1016/j.redox.2019.101390↗
- Paper ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1. DOI 10.2139/ssrn.3439545↗
- Tao Li · 1 shared paper, 2019 · strength 0.10
- Rui Wang · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.